This study, which was conducted by Dr. Joshua Aviram as part of his postdoctoral fellowship, is the first to assess the possible benefits of medical cannabis for cancer-related pain in oncology patients.
‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler
An article on Benzinga highlighting the innovative SyqeAir Inhaler and its role in addressing the global challenge of cannabis overdose through metered dosing. Read what the CEO of SyqeAir, Hagit Kamin, had to say about this.